228 related articles for article (PubMed ID: 21501130)
1. A comparison of low vs conventional-dose heparin for minimal cardiopulmonary bypass in coronary artery bypass grafting surgery.
Fromes Y; Daghildjian K; Caumartin L; Fischer M; Rouquette I; Deleuze P; Bical OM
Anaesthesia; 2011 Jun; 66(6):488-92. PubMed ID: 21501130
[TBL] [Abstract][Full Text] [Related]
2. How much heparin do we really need to go on pump? A rethink of current practices.
Shuhaibar MN; Hargrove M; Millat MH; O'Donnell A; Aherne T
Eur J Cardiothorac Surg; 2004 Nov; 26(5):947-50. PubMed ID: 15519187
[TBL] [Abstract][Full Text] [Related]
3. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization.
Mullen JC; Bentley MJ; Gelfand ET; Koshal A; Modry DL; Guenther CR; Etches WS; Stang LJ; Lopushinsky SR
Can J Surg; 2002 Jun; 45(3):166-72. PubMed ID: 12067167
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
[TBL] [Abstract][Full Text] [Related]
5. Use of heparin-coated cardiopulmonary bypass circuit with low-dose heparin reduces postoperative bleeding.
Suehiro S; Shibata T; Sasaki Y; Hattori K; Kumano H; Hosono M; Kinoshita H
Ann Thorac Cardiovasc Surg; 1999 Aug; 5(4):225-9. PubMed ID: 10508946
[TBL] [Abstract][Full Text] [Related]
6. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of heparin-coated circuits with full heparin dose strategy.
Sinci V; Kalaycioglu S; Gunaydin S; Imren Y; Gokgoz L; Soncul H; Ersoz A
Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761
[TBL] [Abstract][Full Text] [Related]
8. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
9. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
Ovrum E; Am Holen E; Tangen G; Ringdal MA
Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
[TBL] [Abstract][Full Text] [Related]
10. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
12. Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting.
Øvrum E; Tangen G; Tølløfsrud S; Skeie B; Ringdal MA; Istad R; Øystese R
J Thorac Cardiovasc Surg; 2011 May; 141(5):1145-9. PubMed ID: 20709334
[TBL] [Abstract][Full Text] [Related]
13. Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery.
Kreisler KR; Vance RA; Cruzzavala J; Mahnken JD
J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):608-11. PubMed ID: 16202894
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting.
Mirow N; Minami K; Kleikamp G; Tenderich G; Puhlmann T; Körfer R
Thorac Cardiovasc Surg; 2001 Jun; 49(3):131-6. PubMed ID: 11432470
[TBL] [Abstract][Full Text] [Related]
15. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study.
Aldea GS; Doursounian M; O'Gara P; Treanor P; Shapira OM; Lazar HL; Shemin RJ
Ann Thorac Surg; 1996 Aug; 62(2):410-7; discussion 417-8. PubMed ID: 8694599
[TBL] [Abstract][Full Text] [Related]
16. Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial.
Arsenault KA; Paikin JS; Hirsh J; Dale B; Whitlock RP; Teoh K; Young E; Ginsberg JS; Weitz JI; Eikelboom JW
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):944-950.e3. PubMed ID: 22743176
[TBL] [Abstract][Full Text] [Related]
17. Changing systems for measuring activated clotting times: impact on the clinical practice of heparin anticoagulation during cardiac surgery.
Patteril M; Stafford-Smith M; Toffaletti JG; Bute BP; Milano CA; Welsby IJ
Clin Chim Acta; 2005 Jun; 356(1-2):218-24. PubMed ID: 15936321
[TBL] [Abstract][Full Text] [Related]
18. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
Shore-Lesserson L; Reich DL; DePerio M
Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R
J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738
[TBL] [Abstract][Full Text] [Related]
20. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
